Oxcarbazepine for neuropathic pain

Area of Science:

• Neurology
• Pharmacology
• Pain Management

Background:

• Oxcarbazepine is an anticonvulsant drug used for neuropathic pain, with mixed evidence on its efficacy.
• This review updates a 2013 analysis, comparing oxcarbazepine to placebo or other interventions.

Purpose of the Study:

• To assess the benefits and harms of oxcarbazepine for various types of neuropathic pain.
• Evaluate oxcarbazepine's efficacy in conditions like painful diabetic peripheral neuropathy and radiculopathy.

Main Methods:

• Searched multiple databases (Cochrane, MEDLINE, Embase) and clinical trial registries up to January 2017.
• Included randomized controlled trials (RCTs) and cross-over studies of oxcarbazepine for neuropathic pain, with a minimum treatment duration of six weeks.

Main Results:

• Five RCTs (862 participants) were included, focusing on painful diabetic peripheral neuropathy (DPN), radiculopathy, and mixed neuropathies.
• Limited evidence suggests oxcarbazepine may offer some pain reduction in DPN (30-50% reduction) but with high risk of bias and imprecision.
• Serious adverse events were more common with oxcarbazepine (8.3% vs. 2.5% placebo) in DPN, and more participants withdrew due to adverse effects across all studied conditions.

Conclusions:

• Little evidence supports oxcarbazepine's effectiveness for DPN, radiculopathy, or mixed neuropathies, with very low confidence in observed effects.
• Adverse effects and discontinuations due to side effects were more frequent with oxcarbazepine compared to placebo.
• Further well-designed RCTs are needed to clarify oxcarbazepine's role in neuropathic pain management, avoiding publication bias.